JNCCN-360

Editor:

Karl D. Lewis, MD

Advertisement

Advertisement

Eric Roeland, MD, on Chemotherapy-Induced Vomiting: Adherence to Guidelines

Steven M. Horwitz, MD, on PTCL and CTCL: Trial Results on Cerdulatinib and NCCN Practice Guidelines

Charles von Gunten, MD, PhD, on Protecting Opioid Access: NCCN Guideline Recommendations

Recent

Pilot Study of Toll-Like Receptor 4 Agonist in Merkel Cell Carcinoma

Srcasm Levels: Potential Therapeutic Target in Skin Cancer

Pembrolizumab Approved for Merkel Cell Carcinoma by the FDA

Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England

Published

Medical Literature

Risk Factors of Aggressive Skin Cancer in Recipients of Solid Organ Transplants

Research Points to Certain Genetic Links to Cutaneous Squamous Cell Carcinoma

Organ Transplantation and Degree of Differentiation of Cutaneous Squamous Cell Carcinoma

Risk of New Skin Neoplasms in Patients With History of Skin Cancer

Ongoing

The Evolving Role of Biomarkers in Oncology

PD-L1 Expression Testing

Immunotherapy for cSCC: How, Why, and When (login required)

How to Effectively Manage Patients With Cutaneous Squamous Cell Carcinoma: Live From ASCO (login required)

Available

Clinical Trials

Stanford Cancer Institute

The Sidney Kimmel Comprehensive Cancer Center

The University of Alabama at Birmingham Comprehensive Cancer Center

Seidman Cancer Center

Sections

NCCN Resources

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.